Meribank Biotech has signed a letter of intent with Ahead Medicine and Apexcella Biomedical, focusing on optimizing allogeneic natural killer (NK) cell manufacturing and building an AI-based immune cell detection platform. The collaboration aims to strengthen...
The article requires paid subscription.
Subscribe Now